Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives-Reference-Cited by-同舟云学术

Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives

Published:2012-03 Issue:3 Volume:12 Page:240-248
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Hurt Aeron C,Chotpitayasunondh Tawee,Cox Nancy J,Daniels Rod,Fry Alicia M,Gubareva Larisa V,Hayden Frederick G,Hui David S,Hungnes Olav,Lackenby Angie,Lim Wilina,Meijer Adam,Penn Charles,Tashiro Masato,Uyeki Timothy M,Zambon Maria

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference87 articles.

1. Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season;Meijer;Euro Surveill,2007

2. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir;Reddy;J Antimicrob Chemother,2010

3. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro;Gubareva;Antivir Ther,2010

4. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group;Nicholson;Lancet,2000

5. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir;Gubareva;J Infect Dis,2001

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro;Antiviral Research;2024-09

2. Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States;Infectious Diseases and Therapy;2024-08-16

3. Inhibition of RAN attenuates influenza a virus replication and nucleoprotein nuclear export;Emerging Microbes & Infections;2024-08-12

4. Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study;Frontiers in Microbiology;2024-07-23

5. Influenza A defective viral genome production is altered by metabolites, metabolic signaling molecules, and cyanobacteria extracts;2024-07-06